Serum autoantibodies against the extracellular region of α6β4 integrin in a patient with dipeptidyl peptidase-4 inhibitor-induced bullous pemphigoid

Chigusa Yamashita; Noriko Arase; Shuhei Higuchi; Hisashi Arase; Junichi Takagi; Satoshi Nojima; Atsushi Tanemura; Manabu Fujimoto

doi:10.1016/j.jdcr.2021.12.021

Serum autoantibodies against the extracellular region of α6β4 integrin in a patient with dipeptidyl peptidase-4 inhibitor-induced bullous pemphigoid

JAAD Case Rep. 2021 Dec 23:20:65-68. doi: 10.1016/j.jdcr.2021.12.021. eCollection 2022 Feb.

Authors

Chigusa Yamashita¹, Noriko Arase¹, Shuhei Higuchi², Hisashi Arase^{2

3}, Junichi Takagi⁴, Satoshi Nojima⁵, Atsushi Tanemura¹, Manabu Fujimoto^{1

6}

Affiliations

¹ Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
² Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
³ Laboratory of Immunochemistry, World Premier International Immunology Frontier Research Center, Osaka University, Osaka, Japan.
⁴ Laboratory for Protein Synthesis and Expression, Institute of Protein Research, Osaka University, Osaka, Japan.
⁵ Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.
⁶ Laboratory of Cutaneous Immunology, World Premier International Immunology Frontier Research Center, Osaka University, Osaka, Japan.

No abstract available

Keywords: BP, bullous pemphigoid; DPP-4, dipeptidyl peptidase-4; IgG, immunoglobulin G; autoantibody; blister; bullous pemphigoid; dipeptidyl peptidase-4 inhibitors; extracellular domain; α6β4 integrin.

Publication types

Case Reports